Lantern Pharma Inc. (NASDAQ: LTRN) Launches AI Tool to Predict Efficacy of Cancer Drug Combinations
Lantern Pharma has introduced an AI-powered module within its RADR(R) platform to assess DDA-DDRi combination therapies. The module uses genomic,…
Lantern Pharma has introduced an AI-powered module within its RADR(R) platform to assess DDA-DDRi combination therapies. The module uses genomic,…
Lantern Pharma (NASDAQ: LTRN) announced that its wholly owned subsidiary, Starlight Therapeutics, has received FDA clearance for an Investigational New…
The FDA-cleared HeartBeam system enables patients and physicians to access significant arrhythmia data outside traditional clinical settings. The HeartBeam system,…
Mullen Automotive recently brought all of its EV products and brands together under one strong and unified identity — Bollinger…
Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, announced $7,500 in additional price adjustments for commercial customers purchasing existing inventory…
Drug delivery plays a critical role in modern healthcare, but when it comes to potent opioids such as fentanyl, the…
NextPlat (NASDAQ: NXPL, NXPLW) a global provider of healthcare and technology solutions, will release its financial results for the quarter…
Safe Pro Group (NASDAQ: SPAI), a leader in AI-powered defense and security solutions, welcomed the FAA’s proposed rules to streamline…
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) announced assay results from the first five holes of its restarted definition…
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) emphasized the global trends driving demand for advanced breast cancer imaging technologies and…